Chas McKhann
CIK 1631746 · Chief Executive Officer · last filed 2026-04-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
12
Lifetime Open-Market Net
-$1.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COCHW | Director | — | $0.05 | — | $0 | 1 | 2026-04-17 |
| Silk Road Medical Inc (SILK) Delisted | Chief Executive Officer | 1,299,042 | $27.49 | $35.71M | $0 | 3 | 2024-09-18 |
| Apollo Endosurgery, Inc. (APEN) Delisted | President and CEO | 0 | $10.00 | $0 | -$1.01M | 6 | 2023-04-04 |
| Intersect ENT, Inc. (XENT) Delisted | Chief Commercial Officer | — | $28.24 | — | $0 | 2 | 2016-01-20 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-20 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-02-03 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.